Teewinot Capital Advisers’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-15,202
Closed -$3.72M 32
2026
Q1
$3.72M Buy
+15,202
New +$3.54M 0.3% 26
2025
Q3
Sell
-227,513
Closed -$34.8M 39
2025
Q2
$34.8M Buy
227,513
+15,467
+7% +$2.38M 2.86% 16
2025
Q1
$35.2M Buy
+212,046
New +$33.2M 3.59% 15
2023
Q1
Sell
-59,710
Closed -$10.5M 34
2022
Q4
$10.5M Sell
59,710
-58,477
-49% -$10.1M 2.36% 18
2022
Q3
$19.3M Buy
+118,187
New +$20M 4.42% 14

Other funds holding JNJ

Teewinot Capital Advisers's JNJ Position: Q2 2026 in Review

Teewinot Capital Advisers sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 15,202 shares — an estimated $3.72M sold.

Teewinot Capital Advisers first reported a position in JNJ in Q3 2022 and held it in 5 quarters. The position peaked at $35.2M in Q1 2025. 4,688 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Teewinot Capital Advisers reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • Teewinot Capital Advisers sold 15,202 Johnson & Johnson shares in Q2 2026, an estimated $3.72M.
  • Teewinot Capital Advisers first reported a position in Johnson & Johnson in Q3 2022 and held it in 5 quarters.
  • Teewinot Capital Advisers's Johnson & Johnson position peaked at $35.2M in Q1 2025.
  • 4,688 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Teewinot Capital Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.